Home
Contact Us
Site Map
Home
> Investors
Investors
News Releases
6/20/2008
King Pharmaceuticals to Present at Leerink Swann Pain Roundtable Conference
6/17/2008
Acurox™ Tablets Meet Primary Endpoint In Pivotal Phase III Study
6/10/2008
Pain Therapeutics and King Pharmaceuticals Announce Submission Of New Drug Application for Remoxy™
6/9/2008
King Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
5/27/2008
King Pharmaceuticals Exercises Option to License Third Opioid Product Utilizing Acura's AVERSION® Technology
read more »
Home
About Us
Products
Investors
Business Development
Careers
Community
Contact Us
Site Map
Legal
©2000-2008 King Pharmaceuticals,
®
Inc. All rights reserved.
About Us
Vision
Who We Are
Why Choose King?
Strategy
Fast Facts
Products
Avinza® CII
Skelaxin®
Thrombin-JMI®
Altace®
Sonata® CIV
Levoxyl®
Meridian Auto injector Products/EpiPen®
Alphabetic Listing of Products
NDC Listing of Products
Authorized Distributors of Record
Investors
News Releases
Annual Report
SEC Documents
SEC Section 16 Reports
Governance
Webcasts
Business Development
Careers
Job Search
Benefits
Culture and Diversity
Why Choose King?
Locations
Community
News Releases
Annual Report
SEC Documents
SEC Section 16 Reports
Governance
Webcasts
